KEGG   PATHWAY: anu05200
Entry
anu05200                    Pathway                                
Name
Pathways in cancer - Arvicanthis niloticus (African grass rat)
Class
Human Diseases; Cancer: overview
Pathway map
anu05200  Pathways in cancer
anu05200

Organism
Arvicanthis niloticus (African grass rat) [GN:anu]
Gene
117720198  Dcc; netrin receptor DCC [KO:K06765]
117721984  Casp3; caspase-3 [KO:K02187] [EC:3.4.22.56]
117708916  Casp9; caspase-9 [KO:K04399] [EC:3.4.22.62]
117705146  Appl1; DCC-interacting protein 13-alpha isoform X1 [KO:K08733]
117722998  Cdh1; cadherin-1 [KO:K05689]
117693212  Ctnnb1; catenin beta-1 [KO:K02105]
117714786  Ctnna2; catenin alpha-2 isoform X1 [KO:K05691]
117724798  Ctnna3; catenin alpha-3 isoform X1 [KO:K05691]
117719541  Ctnna1; catenin alpha-1 isoform X1 [KO:K05691]
117710223  Axin1; axin-1 isoform X1 [KO:K02157]
117710764  Axin2; axin-2 [KO:K04385]
117719879  Apc; adenomatous polyposis coli protein isoform X1 [KO:K02085]
117696137  Apc2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
117718295  Gsk3b; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
117710774  Tcf7; transcription factor 7 isoform X1 [KO:K02620]
117715247  Tcf7l1; transcription factor 7-like 1 isoform X1 [KO:K04490]
117718257  Tcf7l2; transcription factor 7-like 2 isoform X1 [KO:K04491]
117706912  Lef1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
117711130  Birc5; baculoviral IAP repeat-containing protein 5 [KO:K08731]
117719150  Myc; myc proto-oncogene protein [KO:K04377]
117695826  myc proto-oncogene protein-like [KO:K04377]
117695848  myc proto-oncogene protein-like [KO:K04377]
117696009  myc proto-oncogene protein-like [KO:K04377]
117711496  Ccnd1; G1/S-specific cyclin-D1 isoform X1 [KO:K04503]
117719132  Wnt1; proto-oncogene Wnt-1 [KO:K03209]
117707808  Wnt2b; protein Wnt-2b [KO:K00182]
117720625  Wnt2; protein Wnt-2 [KO:K00182]
117711043  Wnt3a; protein Wnt-3a [KO:K00312]
117711124  Wnt3; proto-oncogene Wnt-3 [KO:K00312]
117708522  Wnt4; protein Wnt-4 [KO:K00408]
117714850  Wnt5b; protein Wnt-5b isoform X1 [KO:K00444]
117705984  Wnt5a; protein Wnt-5a isoform X1 [KO:K00444]
117705525  Wnt6; protein Wnt-6 [KO:K00445]
117715606  Wnt7a; protein Wnt-7a [KO:K00572]
117718736  Wnt7b; protein Wnt-7b isoform X1 [KO:K00572]
117723524  Wnt8b; protein Wnt-8b [KO:K00714]
117719527  Wnt8a; LOW QUALITY PROTEIN: protein Wnt-8a [KO:K00714]
117711739  Wnt9b; protein Wnt-9b [KO:K01064]
117711758  Wnt9a; protein Wnt-9a [KO:K01064]
117705409  Wnt10a; protein Wnt-10a isoform X1 [KO:K01357]
117719001  Wnt10b; protein Wnt-10b [KO:K01357]
117723911  Wnt11; protein Wnt-11 isoform X1 [KO:K01384]
117720614  Wnt16; protein Wnt-16 [KO:K01558]
117706218  Fzd7; frizzled-7 [KO:K02432]
117720668  Fzd1; frizzled-1 [KO:K02432]
117711178  Fzd2; frizzled-2 [KO:K02235]
117706086  Fzd3; frizzled-3 [KO:K02329]
117722634  Fzd4; frizzled-4 [KO:K02354]
117705098  Fzd5; frizzled-5 [KO:K02375]
117714080  Fzd8; frizzled-8 [KO:K02375]
117719203  Fzd6; frizzled-6 [KO:K02376]
117698106  Fzd9; frizzled-9 [KO:K02842]
117698132  Fzd10; frizzled-10 [KO:K02842]
117715360  Lrp6; low-density lipoprotein receptor-related protein 6 [KO:K03068]
117710726  Lrp5; low-density lipoprotein receptor-related protein 5 [KO:K03068]
117711752  Dvl2; segment polarity protein dishevelled homolog DVL-2 [KO:K02353]
117717957  Dvl3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353]
117708963  Dvl1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
117698570  Frat1; proto-oncogene FRAT1 [KO:K03069]
117696584  proto-oncogene FRAT1-like [KO:K03069]
117698585  Frat2; GSK-3-binding protein FRAT2 [KO:K03096]
117702785  F2; prothrombin isoform X1 [KO:K01313] [EC:3.4.21.5]
117722914  Agt; angiotensinogen [KO:K09821]
117701700  angiotensinogen [KO:K09821]
117700330  F2r; proteinase-activated receptor 1 [KO:K03914]
117721980  F2rl3; proteinase-activated receptor 4 [KO:K04236]
117709214  Lpar1; lysophosphatidic acid receptor 1 isoform X1 [KO:K04289]
117721947  Lpar2; lysophosphatidic acid receptor 2 [KO:K04291]
117707186  Lpar3; lysophosphatidic acid receptor 3 [KO:K04294]
117694628  Lpar4; lysophosphatidic acid receptor 4 [KO:K04275]
117714911  Lpar5; lysophosphatidic acid receptor 5 [KO:K08390]
117705265  Lpar6; lysophosphatidic acid receptor 6 [KO:K04273]
117707297  Agtr1; type-1 angiotensin II receptor [KO:K04166]
117713323  type-1A angiotensin II receptor [KO:K04166]
117698098  Gna12; guanine nucleotide-binding protein subunit alpha-12 [KO:K04346]
117711084  Gna13; guanine nucleotide-binding protein subunit alpha-13 isoform X1 [KO:K04639]
117699191  Arhgef12; rho guanine nucleotide exchange factor 12 isoform X1 [KO:K07532]
117707622  Arhgef11; rho guanine nucleotide exchange factor 11 isoform X1 [KO:K12331]
117711152  Arhgef1; rho guanine nucleotide exchange factor 1 isoform X1 [KO:K12330]
117709138  Plekhg5; pleckstrin homology domain-containing family G member 5 isoform X1 [KO:K19464]
117715446  transforming protein RhoA-like [KO:K04513]
117725075  Rhoa; transforming protein RhoA [KO:K04513]
117719597  Rock1; rho-associated protein kinase 1 isoform X1 [KO:K04514] [EC:2.7.11.1]
117716790  Rock2; rho-associated protein kinase 2 [KO:K17388] [EC:2.7.11.1]
117715074  Cxcl12; stromal cell-derived factor 1 [KO:K10031]
117701531  stromal cell-derived factor 1-like [KO:K10031]
117716225  Cxcr4; C-X-C chemokine receptor type 4 [KO:K04189]
117706851  Gnai3; guanine nucleotide-binding protein G(i) subunit alpha [KO:K04630]
117693315  Gnai2; guanine nucleotide-binding protein G(i) subunit alpha-2 [KO:K04630]
117720623  Gnai1; guanine nucleotide-binding protein G(i) subunit alpha-1 [KO:K04630]
117722946  Ptger1; prostaglandin E2 receptor EP1 subtype isoform X1 [KO:K04258]
117705736  Ptger2; prostaglandin E2 receptor EP2 subtype [KO:K04259]
117707912  Ptger3; prostaglandin E2 receptor EP3 subtype isoform X1 [KO:K04260]
117723672  Ptger4; prostaglandin E2 receptor EP4 subtype isoform X1 [KO:K04261]
117703732  neuroendocrine secretory protein 55 [KO:K04632]
117703734  guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas isoform X1 [KO:K04632]
117712590  Adcy1; adenylate cyclase type 1 isoform X1 [KO:K08041] [EC:4.6.1.1]
117723703  Adcy2; adenylate cyclase type 2 [KO:K08042] [EC:4.6.1.1]
117716811  Adcy3; adenylate cyclase type 3 isoform X1 [KO:K08043] [EC:4.6.1.1]
117704978  Adcy4; adenylate cyclase type 4 isoform X1 [KO:K08044] [EC:4.6.1.1]
117717749  Adcy5; adenylate cyclase type 5 [KO:K08045] [EC:4.6.1.1]
117718589  Adcy6; adenylate cyclase type 6 [KO:K08046] [EC:4.6.1.1]
117723273  Adcy7; adenylate cyclase type 7 [KO:K08047] [EC:4.6.1.1]
117718712  Adcy8; adenylate cyclase type 8 isoform X1 [KO:K08048] [EC:4.6.1.1]
117710708  Adcy9; adenylate cyclase type 9 [KO:K08049] [EC:4.6.1.1]
117723055  Prkaca; cAMP-dependent protein kinase catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
117706647  Prkacb; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
117708200  Gnb1; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 [KO:K04536]
117698102  Gnb2; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 [KO:K04537]
117715413  Gnb3; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 [KO:K07825]
117706580  Gnb4; guanine nucleotide-binding protein subunit beta-4 [KO:K04538]
117712557  Gnb5; guanine nucleotide-binding protein subunit beta-5 [KO:K04539]
117705975  Gng2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 [KO:K07826]
117715090  Gng3; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 [KO:K04540]
117713460  Gng4; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 [KO:K04541]
117706732  Gng5; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 [KO:K04542]
117696108  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5-like [KO:K04542]
117696807  Gng7; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 [KO:K04543]
117700356  Gng8; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 [KO:K04544]
117708609  Gng10; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 [KO:K04545]
117720362  Gng11; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 [KO:K04546]
117715105  Gng12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 [KO:K04347]
117723254  Gng14; putative guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-14 [KO:K04347]
117709797  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 [KO:K04547]
117710798  Gng13; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 [KO:K04547]
117720345  Gngt1; guanine nucleotide-binding protein G(T) subunit gamma-T1 [KO:K04548]
117702509  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 [KO:K04549]
117709843  Gngt2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 [KO:K04549]
117722158  Col4a3; collagen alpha-3(IV) chain [KO:K06237]
117722162  Col4a4; collagen alpha-4(IV) chain [KO:K06237]
117694087  Col4a5; LOW QUALITY PROTEIN: collagen alpha-5(IV) chain [KO:K06237]
117694384  Col4a6; collagen alpha-6(IV) chain [KO:K06237]
117721417  Col4a1; collagen alpha-1(IV) chain [KO:K06237]
117721418  Col4a2; collagen alpha-2(IV) chain [KO:K06237]
117700968  Lama2; laminin subunit alpha-2 isoform X1 [KO:K05637]
117693448  Lama1; laminin subunit alpha-1 [KO:K05637]
117703277  Lama5; laminin subunit alpha-5 [KO:K06240]
117719995  Lama3; laminin subunit alpha-3 isoform X1 [KO:K06240]
117724440  Lama4; laminin subunit alpha-4 [KO:K06241]
117716971  Lamb1; laminin subunit beta-1 [KO:K05636]
117693318  Lamb2; laminin subunit beta-2 [KO:K06243]
117716578  Lamb3; laminin subunit beta-3 [KO:K06244]
117716136  Lamc1; laminin subunit gamma-1 [KO:K05635]
117716126  Lamc2; laminin subunit gamma-2 [KO:K06246]
117704476  Lamc3; laminin subunit gamma-3 isoform X1 [KO:K06247]
117705295  Fn1; fibronectin isoform X1 [KO:K05717]
117723944  Itga2; integrin alpha-2 [KO:K06481]
117709947  Itga2b; integrin alpha-IIb [KO:K06476]
117710875  Itga3; integrin alpha-3 isoform X1 [KO:K06482]
117703057  Itga6; integrin alpha-6 isoform X1 [KO:K06485]
117702960  Itgav; integrin alpha-V isoform X1 [KO:K06487]
117723085  Itgb1; integrin beta-1 [KO:K05719]
117718495  Ptk2; focal adhesion kinase 1 isoform X1 [KO:K05725] [EC:2.7.10.2]
117706649  Pik3ca; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
117693421  Pik3cb; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
117708986  Pik3cd; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:2.7.1.153]
117721973  Pik3r2; phosphatidylinositol 3-kinase regulatory subunit beta isoform X1 [KO:K02649]
117723761  Pik3r1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
117708961  phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649]
117697279  Pten; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
117706349  Nkx3-1; homeobox protein Nkx-3.1 [KO:K09348]
117697536  Akt1; RAC-alpha serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
117706636  Akt2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
117721481  Akt3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
117701914  inhibitor of nuclear factor kappa-B kinase subunit alpha-like [KO:K04467] [EC:2.7.11.10]
117712831  Chuk; inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X1 [KO:K04467] [EC:2.7.11.10]
117721547  Ikbkb; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
117695513  Ikbkg; NF-kappa-B essential modulator isoform X1 [KO:K07210]
117717335  Nfkbia; NF-kappa-B inhibitor alpha [KO:K04734]
117707042  Nfkb1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
117706853  Nfkb2; nuclear factor NF-kappa-B p100 subunit isoform X1 [KO:K04469]
117722582  Rela; transcription factor p65 [KO:K04735]
117716475  Ptgs2; prostaglandin G/H synthase 2 [KO:K11987] [EC:1.14.99.1]
117710677  Nos2; nitric oxide synthase, inducible isoform X1 [KO:K13241] [EC:1.14.13.39]
117716348  Bcl2; apoptosis regulator Bcl-2 isoform X1 [KO:K02161]
117699887  baculoviral IAP repeat-containing protein 2 [KO:K16060]
117699964  baculoviral IAP repeat-containing protein 3 [KO:K16060]
117694154  Xiap; E3 ubiquitin-protein ligase XIAP [KO:K04725] [EC:2.3.2.27]
117702668  Birc7; baculoviral IAP repeat-containing protein 7 isoform X1 [KO:K16061]
117703673  Bcl2l1; bcl-2-like protein 1 [KO:K04570]
117703605  Traf1; TNF receptor-associated factor 1 [KO:K03172]
117710914  Traf2; TNF receptor-associated factor 2 [KO:K03173] [EC:2.3.2.27]
117697234  Traf3; TNF receptor-associated factor 3 [KO:K03174]
117711719  Traf4; TNF receptor-associated factor 4 [KO:K09848]
117716371  Traf5; TNF receptor-associated factor 5 [KO:K09849]
117703656  Traf6; TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
117709409  Mtor; serine/threonine-protein kinase mTOR [KO:K07203] [EC:2.7.11.1]
117710017  Rps6kb1; ribosomal protein S6 kinase beta-1 isoform X1 [KO:K04688] [EC:2.7.11.1]
117714029  Rps6kb2; ribosomal protein S6 kinase beta-2 isoform X1 [KO:K04688] [EC:2.7.11.1]
117706557  Bad; bcl2-associated agonist of cell death isoform X1 [KO:K02158]
117706979  Foxo1; forkhead box protein O1 [KO:K07201]
117696339  Mdm2; E3 ubiquitin-protein ligase Mdm2 isoform X1 [KO:K06643] [EC:2.3.2.27]
117710574  Tp53; cellular tumor antigen p53 [KO:K04451]
117715314  Cdkn1b; cyclin-dependent kinase inhibitor 1B [KO:K06624]
117724897  Cdkn1a; cyclin-dependent kinase inhibitor 1 [KO:K06625]
117724340  Bcr; breakpoint cluster region protein isoform X1 [KO:K08878] [EC:2.7.11.1]
117702844  Abl1; tyrosine-protein kinase ABL1 isoform X1 [KO:K06619] [EC:2.7.10.2]
117717801  Crkl; crk-like protein [KO:K04438]
117710148  Crk; adapter molecule crk isoform X1 [KO:K04438]
117698924  Cbl; E3 ubiquitin-protein ligase CBL [KO:K04707] [EC:2.3.2.27]
117710476  signal transducer and activator of transcription 5A [KO:K11223]
117710053  signal transducer and activator of transcription 5B [KO:K11224]
117724854  Pim1; serine/threonine-protein kinase pim-1 [KO:K04702] [EC:2.7.11.1]
117693983  Pim2; serine/threonine-protein kinase pim-2 [KO:K08806] [EC:2.7.11.1]
117717902  Kng1; kininogen-1 isoform X1 [KO:K03898]
117718001  LOW QUALITY PROTEIN: kininogen-1-like [KO:K03898]
117713961  Edn1; endothelin-1 [KO:K16366]
117697373  Bdkrb1; B1 bradykinin receptor [KO:K03915]
117696945  Bdkrb2; B2 bradykinin receptor [KO:K03916]
117723408  Ednra; endothelin-1 receptor [KO:K04197]
117705533  Ednrb; endothelin receptor type B [KO:K04198]
117705469  Gnaq; guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
117696350  Gna11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
117712005  Plcb3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 isoform X1 [KO:K05858] [EC:3.1.4.11]
117703017  Plcb4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
117703351  Plcb1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 [KO:K05858] [EC:3.1.4.11]
117703529  Plcb2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
117709948  Prkca; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
117717067  Prkcb; protein kinase C beta type [KO:K19662] [EC:2.7.11.13]
117701003  Prkcg; protein kinase C gamma type isoform X1 [KO:K19663] [EC:2.7.11.13]
117707066  Il2; interleukin-2 [KO:K05429]
117710315  interleukin-3-like [KO:K04736]
117710319  Il4; interleukin-4 [KO:K05430]
117709822  Il5; interleukin-5 [KO:K05428]
117720807  Il6; interleukin-6 [KO:K05405]
117719170  Il7; interleukin-7 isoform X1 [KO:K05431]
117707571  Il12a; interleukin-12 subunit alpha [KO:K05406]
117711474  Il12b; interleukin-12 subunit beta [KO:K05425]
117711969  Il13; interleukin-13 [KO:K05435]
117723173  Il15; interleukin-15 isoform X1 [KO:K05433]
117696811  Il23a; interleukin-23 subunit alpha [KO:K05426]
117698316  Epo; erythropoietin isoform X1 [KO:K05437]
117708733  interferon alpha-12-like [KO:K05414]
117709002  interferon alpha-12-like [KO:K05414]
117709023  interferon alpha-9 [KO:K05414]
117709053  interferon alpha-1-like [KO:K05414]
117709056  interferon alpha-1-like isoform X1 [KO:K05414]
117709071  interferon alpha-7-like [KO:K05414]
117709072  interferon alpha-12-like [KO:K05414]
117709075  interferon alpha-12-like [KO:K05414]
117709078  interferon alpha-12-like [KO:K05414]
117709079  interferon alpha-1 [KO:K05414]
117709081  interferon alpha-12-like [KO:K05414]
117709083  interferon alpha-12-like [KO:K05414]
117709084  interferon alpha-7 [KO:K05414]
117709085  interferon alpha-12-like [KO:K05414]
117709086  interferon alpha-7-like [KO:K05414]
117709102  interferon alpha-1-like [KO:K05414]
117696651  Ifng; interferon gamma [KO:K04687]
117714153  Il2ra; interleukin-2 receptor subunit alpha [KO:K05068]
117719030  Il2rb; interleukin-2 receptor subunit beta isoform X1 [KO:K05069]
117694639  Il2rg; cytokine receptor common subunit gamma isoform X1 [KO:K05070]
117716491  interleukin-3 receptor subunit alpha-like [KO:K04737]
117721253  Il4r; interleukin-4 receptor subunit alpha isoform X1 [KO:K05071]
117718898  cytokine receptor common subunit beta-like isoform X1 [KO:K04738]
117719059  interleukin-3 receptor class 2 subunit beta-like [KO:K04738]
117715577  Il5ra; interleukin-5 receptor subunit alpha isoform X1 [KO:K05067]
117707604  Il6r; interleukin-6 receptor subunit alpha [KO:K05055]
117723760  Il6st; interleukin-6 receptor subunit beta isoform X1 [KO:K05060]
117724027  Il7r; interleukin-7 receptor subunit alpha [KO:K05072]
117721951  Il12rb1; interleukin-12 receptor subunit beta-1 [KO:K05063]
117715472  Il12rb2; interleukin-12 receptor subunit beta-2 isoform X1 [KO:K05064]
117694763  Il13ra1; interleukin-13 receptor subunit alpha-1 [KO:K05076]
117713866  Il15ra; interleukin-15 receptor subunit alpha isoform X1 [KO:K05074]
117714627  Il23r; interleukin-23 receptor [KO:K05065]
117713472  Epor; erythropoietin receptor [KO:K05079]
117718162  Ifnar1; interferon alpha/beta receptor 1 isoform X1 [KO:K05130]
117718170  Ifnar2; interferon alpha/beta receptor 2 [KO:K05131]
117701112  Ifngr1; interferon gamma receptor 1 [KO:K05132]
117718220  Ifngr2; interferon gamma receptor 2 [KO:K05133]
117716797  Eml4; echinoderm microtubule-associated protein-like 4 isoform X1 [KO:K15420]
117717196  Alk; ALK tyrosine kinase receptor [KO:K05119] [EC:2.7.10.1]
117703370  Rasgrp1; RAS guanyl-releasing protein 1 isoform X1 [KO:K04350]
117709994  Rasgrp2; RAS guanyl-releasing protein 2 isoform X1 [KO:K12361]
117717216  Rasgrp3; ras guanyl-releasing protein 3 isoform X1 [KO:K12362]
117720118  Rasgrp4; RAS guanyl-releasing protein 4 isoform X1 [KO:K12363]
117709127  Jak1; tyrosine-protein kinase JAK1 [KO:K11217] [EC:2.7.10.2]
117713084  Jak2; tyrosine-protein kinase JAK2 [KO:K04447] [EC:2.7.10.2]
117721499  Jak3; tyrosine-protein kinase JAK3 isoform X1 [KO:K11218] [EC:2.7.10.2]
117710477  Stat3; signal transducer and activator of transcription 3 isoform X1 [KO:K04692]
117705244  Stat1; signal transducer and activator of transcription 1-alpha/beta [KO:K11220]
117696619  Stat2; signal transducer and activator of transcription 2 isoform X1 [KO:K11221]
117705420  Stat4; signal transducer and activator of transcription 4 isoform X1 [KO:K11222]
117696860  Stat6; signal transducer and activator of transcription 6 [KO:K11225]
117722213  Vegfa; vascular endothelial growth factor A isoform X1 [KO:K05448]
117716334  Vegfb; vascular endothelial growth factor B isoform X1 [KO:K16858]
117697288  Pgf; placenta growth factor [KO:K16859]
117695345  Vegfd; vascular endothelial growth factor D isoform X1 [KO:K05449]
117721236  Vegfc; vascular endothelial growth factor C [KO:K05449]
117715660  Tgfa; protransforming growth factor alpha [KO:K08774]
117707556  Egf; pro-epidermal growth factor isoform X1 [KO:K04357]
117712744  Egfr; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
117710649  Erbb2; receptor tyrosine-protein kinase erbB-2 [KO:K05083] [EC:2.7.10.1]
117698163  Pdgfa; platelet-derived growth factor subunit A isoform X1 [KO:K04359]
117718445  Pdgfb; platelet-derived growth factor subunit B [KO:K17386]
117712829  Pdgfra; platelet-derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]
117719688  Pdgfrb; platelet-derived growth factor receptor beta isoform X1 [KO:K05089] [EC:2.7.10.1]
117696437  Igf1; insulin-like growth factor I isoform X1 [KO:K05459]
117715108  Igf2; insulin-like growth factor II isoform X1 [KO:K13769]
117715978  Igf1r; insulin-like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]
117696325  Kitlg; kit ligand isoform X1 [KO:K05461]
117700528  LOW QUALITY PROTEIN: mast/stem cell growth factor receptor Kit-like [KO:K05091] [EC:2.7.10.1]
117713018  Kit; mast/stem cell growth factor receptor Kit isoform X1 [KO:K05091] [EC:2.7.10.1]
117711914  Flt3lg; fms-related tyrosine kinase 3 ligand isoform X1 [KO:K05454]
117697747  Flt3; receptor-type tyrosine-protein kinase FLT3 [KO:K05092] [EC:2.7.10.1]
117720586  Hgf; hepatocyte growth factor isoform X1 [KO:K05460]
117720551  Met; hepatocyte growth factor receptor [KO:K05099] [EC:2.7.10.1]
117720104  Fgf1; fibroblast growth factor 1 isoform X1 [KO:K18496]
117706759  Fgf2; fibroblast growth factor 2 [KO:K18497]
117721842  Fgf20; fibroblast growth factor 20 [KO:K04358]
117696768  Fgf3; fibroblast growth factor 3 [KO:K04358]
117697008  Fgf4; fibroblast growth factor 4 [KO:K04358]
117705560  Fgf17; fibroblast growth factor 17 isoform X1 [KO:K04358]
117715525  Fgf6; fibroblast growth factor 6 [KO:K04358]
117715766  Fgf8; fibroblast growth factor 8 isoform X1 [KO:K04358]
117706309  Fgf9; fibroblast growth factor 9 [KO:K04358]
117724025  Fgf10; fibroblast growth factor 10 [KO:K04358]
117699942  Fgf5; fibroblast growth factor 5 [KO:K04358]
117694706  Fgf16; fibroblast growth factor 16 [KO:K04358]
117703422  Fgf7; fibroblast growth factor 7 [KO:K04358]
117710953  Fgf18; fibroblast growth factor 18 [KO:K04358]
117696425  Fgf22; fibroblast growth factor 22 [KO:K04358]
117695519  Fgf19; fibroblast growth factor 19 [KO:K22603]
117697847  Fgf21; fibroblast growth factor 21 [KO:K22429]
117715613  Fgf23; fibroblast growth factor 23 [KO:K22428]
117722071  Fgfr1; fibroblast growth factor receptor 1 isoform X1 [KO:K04362] [EC:2.7.10.1]
117704198  Fgfr2; fibroblast growth factor receptor 2 isoform X1 [KO:K05093] [EC:2.7.10.1]
117712554  Fgfr3; fibroblast growth factor receptor 3 isoform X1 [KO:K05094] [EC:2.7.10.1]
117713886  Fgfr4; fibroblast growth factor receptor 4 isoform X1 [KO:K05095] [EC:2.7.10.1]
117711195  Grb2; growth factor receptor-bound protein 2 [KO:K04364]
117716781  Sos2; son of sevenless homolog 2 isoform X1 [KO:K03099]
117716983  Sos1; son of sevenless homolog 1 isoform X1 [KO:K03099]
117706664  Hras; GTPase HRas isoform X1 [KO:K02833]
117714902  Kras; GTPase KRas isoform X1 [KO:K07827]
117706966  Nras; GTPase NRas [KO:K07828]
117694504  Araf; serine/threonine-protein kinase A-Raf [KO:K08845] [EC:2.7.11.1]
117721084  Braf; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
117715476  Raf1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
117699009  Map2k1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
117696143  Map2k2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
117717711  Mapk1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
117693439  Mapk3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
117709069  Jun; transcription factor AP-1 [KO:K04448]
117697448  Fos; proto-oncogene c-Fos [KO:K04379]
117699249  Ets1; protein C-ets-1 isoform X1 [KO:K02678]
117699743  interstitial collagenase B-like [KO:K01388] [EC:3.4.24.7]
117699745  interstitial collagenase B [KO:K01388] [EC:3.4.24.7]
117699856  interstitial collagenase A [KO:K01388] [EC:3.4.24.7]
117723004  Mmp2; 72 kDa type IV collagenase [KO:K01398] [EC:3.4.24.24]
117701832  72 kDa type IV collagenase [KO:K01398] [EC:3.4.24.24]
117704142  Mmp9; matrix metalloproteinase-9 [KO:K01403] [EC:3.4.24.35]
117696408  Cdk4; cyclin-dependent kinase 4 isoform X1 [KO:K02089] [EC:2.7.11.22]
117697424  Rps6ka5; ribosomal protein S6 kinase alpha-5 [KO:K04445] [EC:2.7.11.1]
117715252  Ret; proto-oncogene tyrosine-protein kinase receptor Ret isoform X1 [KO:K05126] [EC:2.7.10.1]
117724592  Ccdc6; coiled-coil domain-containing protein 6 [KO:K09288]
117705038  Ncoa4; nuclear receptor coactivator 4 isoform X1 [KO:K09289]
117707235  Ntrk1; high affinity nerve growth factor receptor [KO:K03176] [EC:2.7.10.1]
117706699  Tpm3; tropomyosin alpha-3 chain isoform X1 [KO:K09290]
117716131  Tpr; nucleoprotein TPR [KO:K09291]
117693512  Rassf1; ras association domain-containing protein 1 isoform X1 [KO:K09850]
117716499  Rassf5; ras association domain-containing protein 5 isoform X1 [KO:K08015]
117704245  Stk4; serine/threonine-protein kinase 4 [KO:K04411]
117698921  Dapk2; death-associated protein kinase 2 [KO:K08803] [EC:2.7.11.1]
117713641  Dapk1; death-associated protein kinase 1 isoform X1 [KO:K08803] [EC:2.7.11.1]
117696513  Dapk3; death-associated protein kinase 3 isoform X1 [KO:K08803] [EC:2.7.11.1]
117703352  Plcg1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [KO:K01116] [EC:3.1.4.11]
117723064  Plcg2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859] [EC:3.1.4.11]
117694184  Elk1; ETS domain-containing protein Elk-1 [KO:K04375]
117722538  calmodulin-1-like [KO:K02183]
117697522  Calm1; calmodulin-1 [KO:K02183]
117715216  calmodulin-1-like [KO:K02183]
117716931  Calm2; calmodulin-2 [KO:K02183]
117699053  Calml4; calmodulin-like protein 4 isoform X1 [KO:K02183]
117700456  Calm3; calmodulin-3 [KO:K02183]
117713333  Calml3; calmodulin-like protein 3 [KO:K02183]
117713892  Calml5; calmodulin-like protein 5 [KO:K02183]
117705311  Camk2g; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17]
117707719  Camk2d; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1 [KO:K04515] [EC:2.7.11.17]
117719604  Camk2a; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515] [EC:2.7.11.17]
117713012  Camk2b; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17]
117703478  Ralgds; ral guanine nucleotide dissociation stimulator isoform X1 [KO:K08732]
117714072  Rala; ras-related protein Ral-A [KO:K07834]
117716566  Ralb; ras-related protein Ral-B [KO:K07835]
117693353  Ralbp1; ralA-binding protein 1 [KO:K08773]
117708461  Cdc42; cell division control protein 42 homolog isoform X1 [KO:K04393]
117697870  Rac1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392]
117718817  Rac2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
117710799  Rac3; ras-related C3 botulinum toxin substrate 3 [KO:K07861]
117707206  Pld1; phospholipase D1 isoform X1 [KO:K01115] [EC:3.1.4.4]
117710877  Pld2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]
117705037  Mapk8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
117709966  Mapk9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
117710901  Pax8; paired box protein Pax-8 [KO:K09293]
117715534  Pparg; peroxisome proliferator-activated receptor gamma isoform X1 [KO:K08530]
117703056  Rxra; retinoic acid receptor RXR-alpha [KO:K08524]
117724480  Rxrb; retinoic acid receptor RXR-beta isoform X1 [KO:K08525]
117716555  Rxrg; retinoic acid receptor RXR-gamma isoform X1 [KO:K08526]
117705478  Rarb; retinoic acid receptor beta [KO:K08528]
117700168  Esr1; estrogen receptor isoform X1 [KO:K08550]
117697284  Esr2; estrogen receptor beta isoform X1 [KO:K08551]
117717173  Ncoa1; nuclear receptor coactivator 1 isoform X1 [KO:K09101] [EC:2.3.1.48]
117703461  Ncoa3; nuclear receptor coactivator 3 isoform X1 [KO:K11256] [EC:2.3.1.48]
117718542  Sp1; transcription factor Sp1 isoform X1 [KO:K04684]
117724587  Ppard; peroxisome proliferator-activated receptor delta [KO:K04504]
117710614  Jup; junction plakoglobin [KO:K10056]
117698867  Zbtb16; zinc finger and BTB domain-containing protein 16 [KO:K10055]
117710620  Rara; retinoic acid receptor alpha isoform X1 [KO:K08527]
117706717  Ccna2; cyclin-A2 [KO:K06627]
117707276  Ccna1; cyclin-A1 [KO:K06627]
117698954  Pml; protein PML isoform X1 [KO:K10054] [EC:2.3.2.-]
117717806  Runx1; runt-related transcription factor 1 isoform X1 [KO:K08367]
117698579  Runx1t1; protein CBFA2T1 isoform X1 [KO:K10053]
117703738  Spi1; transcription factor PU.1 [KO:K09438]
117697881  Cebpa; CCAAT/enhancer-binding protein alpha [KO:K09055]
117699159  granulocyte-macrophage colony-stimulating factor receptor subunit alpha-like isoform X1 [KO:K05066]
117709275  Csf3r; granulocyte colony-stimulating factor receptor isoform X1 [KO:K05061]
117720183  Csf1r; macrophage colony-stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]
117709131  cyclin-dependent kinase inhibitor 2A-like [KO:K06621]
117702649  E2f1; transcription factor E2F1 [KO:K17454]
117709432  E2f2; transcription factor E2F2 isoform X1 [KO:K09389]
117713327  E2f3; transcription factor E2F3 [KO:K06620]
117697364  Max; protein max isoform X1 [KO:K04453]
117709302  Zbtb17; zinc finger and BTB domain-containing protein 17 isoform X1 [KO:K10500]
117709603  cyclin-dependent kinase 4 inhibitor B [KO:K04685]
117720333  Cdk6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
117714829  Ccnd2; G1/S-specific cyclin-D2 [KO:K10151]
117722295  Ccnd3; G1/S-specific cyclin-D3 [KO:K10152]
117697988  cyclin-dependent kinases regulatory subunit 2-like [KO:K02219]
117706689  Cks1b; cyclin-dependent kinases regulatory subunit 1 [KO:K02219]
117707816  cyclin-dependent kinases regulatory subunit 1-like [KO:K02219]
117713973  Cks2; cyclin-dependent kinases regulatory subunit 2 [KO:K02219]
117710775  Skp1; S-phase kinase-associated protein 1 [KO:K03094]
117720943  Cul1; cullin-1 [KO:K03347]
117719097  Rbx1; E3 ubiquitin-protein ligase RBX1 [KO:K03868] [EC:2.3.2.32]
117724054  Skp2; S-phase kinase-associated protein 2 [KO:K03875]
117696564  Cdk2; cyclin-dependent kinase 2 isoform X1 [KO:K02206] [EC:2.7.11.22]
117698572  Ccne2; G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
117717876  LOW QUALITY PROTEIN: G1/S-specific cyclin-E2-like [KO:K06626]
117712916  Ccne1; G1/S-specific cyclin-E1 [KO:K06626]
117705264  Rb1; retinoblastoma-associated protein [KO:K06618]
117715599  Gadd45a; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
117713452  Gadd45g; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
117696104  Gadd45b; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
117722249  Bax; apoptosis regulator BAX isoform X1 [KO:K02159]
117724492  Bak1; bcl-2 homologous antagonist/killer isoform X1 [KO:K14021]
117703801  Ddb2; DNA damage-binding protein 2 [KO:K10140]
117700417  Polk; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]
117723948  Tert; telomerase reverse transcriptase isoform X1 [KO:K11126] [EC:2.7.7.49]
117715106  Mitf; microphthalmia-associated transcription factor isoform X1 [KO:K09455]
117713589  Tgfb1; transforming growth factor beta-1 proprotein [KO:K13375]
117716112  Tgfb2; transforming growth factor beta-2 proprotein isoform X1 [KO:K13376]
117697375  Tgfb3; transforming growth factor beta-3 proprotein [KO:K13377]
117708549  Tgfbr1; TGF-beta receptor type-1 isoform X1 [KO:K04674] [EC:2.7.11.30]
117693333  Tgfbr2; TGF-beta receptor type-2 isoform X1 [KO:K04388] [EC:2.7.11.30]
117719725  Smad2; mothers against decapentaplegic homolog 2 isoform X1 [KO:K04500]
117699022  Smad3; mothers against decapentaplegic homolog 3 isoform X1 [KO:K23605]
117719590  Smad4; mothers against decapentaplegic homolog 4 [KO:K04501]
117712584  Ctbp1; C-terminal-binding protein 1 isoform X1 [KO:K04496] [EC:1.1.1.428]
117695071  Ctbp2; C-terminal-binding protein 2 isoform X1 [KO:K04496] [EC:1.1.1.428]
117695532  LOW QUALITY PROTEIN: C-terminal-binding protein 2-like [KO:K04496] [EC:1.1.1.428]
117724593  Hdac2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]
117709000  Hdac1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]
117693750  Mlh1; DNA mismatch repair protein Mlh1 isoform X1 [KO:K08734]
117717069  Msh2; DNA mismatch repair protein Msh2 [KO:K08735]
117700391  Msh3; DNA mismatch repair protein Msh3 [KO:K08736]
117717177  Msh6; DNA mismatch repair protein Msh6 [KO:K08737]
117697744  Brca2; breast cancer type 2 susceptibility protein [KO:K08775]
117703360  Rad51; DNA repair protein RAD51 homolog 1 [KO:K04482]
117716367  Faslg; tumor necrosis factor ligand superfamily member 6 isoform X1 [KO:K04389]
117700780  Fas; tumor necrosis factor receptor superfamily member 6 isoform X1 [KO:K04390]
117710030  Fadd; FAS-associated death domain protein [KO:K02373]
117704983  Casp8; caspase-8 [KO:K04398] [EC:3.4.22.61]
117715167  Bid; BH3-interacting domain death agonist [KO:K04726]
117719540  Pmaip1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]
117700355  Bbc3; bcl-2-binding component 3 isoform X1 [KO:K10132]
117703834  Bcl2l11; bcl-2-like protein 11 isoform X1 [KO:K16341]
117717119  LOW QUALITY PROTEIN: cytochrome c, somatic-like [KO:K08738]
117700217  cytochrome c-like [KO:K08738]
117701548  LOW QUALITY PROTEIN: cytochrome c, somatic-like [KO:K08738]
117720836  cytochrome c, somatic [KO:K08738]
117704117  cytochrome c, testis-specific [KO:K08738]
117696384  Apaf1; apoptotic protease-activating factor 1 [KO:K02084]
117696275  Casp7; caspase-7 [KO:K04397] [EC:3.4.22.60]
117713629  Keap1; kelch-like ECH-associated protein 1 [KO:K10456]
117703103  Nfe2l2; nuclear factor erythroid 2-related factor 2 isoform X1 [KO:K05638]
117723006  Hmox1; heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]
117723471  Nqo1; NAD(P)H dehydrogenase [quinone] 1 [KO:K00355] [EC:1.6.5.2]
117704700  Gsto2; glutathione S-transferase omega-2 [KO:K00799] [EC:2.5.1.18]
117704706  Gsto1; glutathione S-transferase omega-1 [KO:K00799] [EC:2.5.1.18]
117722371  glutathione S-transferase A3 [KO:K00799] [EC:2.5.1.18]
117722373  glutathione S-transferase-like [KO:K00799] [EC:2.5.1.18]
117722423  glutathione S-transferase-like [KO:K00799] [EC:2.5.1.18]
117722532  glutathione S-transferase alpha-3 [KO:K00799] [EC:2.5.1.18]
117715441  Mgst1; microsomal glutathione S-transferase 1 [KO:K00799] [EC:2.5.1.18]
117722661  glutathione S-transferase A6 [KO:K00799] [EC:2.5.1.18]
117712654  glutathione S-transferase alpha-4 [KO:K00799] [EC:2.5.1.18]
117712712  glutathione S-transferase alpha-2-like [KO:K00799] [EC:2.5.1.18]
117716150  Mgst3; microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]
117706587  glutathione S-transferase Mu 1 [KO:K00799] [EC:2.5.1.18]
117706588  glutathione S-transferase Mu 2 [KO:K00799] [EC:2.5.1.18]
117706589  glutathione S-transferase Mu 7 [KO:K00799] [EC:2.5.1.18]
117706590  glutathione S-transferase Mu 2-like isoform X1 [KO:K00799] [EC:2.5.1.18]
117706591  glutathione S-transferase Mu 3 isoform X1 [KO:K00799] [EC:2.5.1.18]
117706595  Gstm4; glutathione S-transferase Mu 4 [KO:K00799] [EC:2.5.1.18]
117724528  glutathione S-transferase theta-3 [KO:K00799] [EC:2.5.1.18]
117724531  glutathione S-transferase theta-1 [KO:K00799] [EC:2.5.1.18]
117724532  glutathione S-transferase theta-4 [KO:K00799] [EC:2.5.1.18]
117707482  Mgst2; microsomal glutathione S-transferase 2 [KO:K00799] [EC:2.5.1.18]
117724949  glutathione S-transferase theta-2 [KO:K00799] [EC:2.5.1.18]
117707765  Gstm3; glutathione S-transferase Mu 3 [KO:K00799] [EC:2.5.1.18]
117712791  glutathione S-transferase alpha-2 [KO:K00799] [EC:2.5.1.18]
117722448  glutathione S-transferase P 2-like [KO:K23790] [EC:2.5.1.18]
117698262  glutathione S-transferase P 1 [KO:K23790] [EC:2.5.1.18]
117698288  glutathione S-transferase P 1 isoform X1 [KO:K23790] [EC:2.5.1.18]
117715514  Txnrd3; thioredoxin reductase 3 isoform X1 [KO:K22182] [EC:1.8.1.9]
117717878  Txnrd2; thioredoxin reductase 2, mitochondrial [KO:K22182] [EC:1.8.1.9]
117696194  Txnrd1; thioredoxin reductase 1, cytoplasmic isoform X1 [KO:K22182] [EC:1.8.1.9]
117715488  Vhl; von Hippel-Lindau disease tumor suppressor [KO:K03871]
117714895  elongin-C-like [KO:K03872]
117716108  elongin-C-like [KO:K03872]
117698724  Eloc; elongin-C [KO:K03872]
117693521  elongin-C-like [KO:K03872]
117710815  elongin-C-like [KO:K03872]
117721292  elongin-C-like [KO:K03872]
117721706  elongin-C [KO:K03872]
117693415  elongin-B-like [KO:K03873]
117710248  elongin-B-like [KO:K03873]
117695486  elongin-B-like [KO:K03873]
117710666  Elob; elongin-B [KO:K03873]
117696130  elongin-B-like [KO:K03873]
117713955  elongin-B-like [KO:K03873]
117713834  Cul2; cullin-2 [KO:K03870]
117723098  Egln1; egl nine homolog 1 isoform X1 [KO:K09592] [EC:1.14.11.29]
117717214  Egln3; egl nine homolog 3 [KO:K09592] [EC:1.14.11.29]
117696281  Egln2; egl nine homolog 2 isoform X1 [KO:K09592] [EC:1.14.11.29]
117721822  Fh; fumarate hydratase, mitochondrial [KO:K01679] [EC:4.2.1.2]
117697105  Hif1a; hypoxia-inducible factor 1-alpha isoform X1 [KO:K08268]
117716791  Epas1; endothelial PAS domain-containing protein 1 isoform X1 [KO:K09095]
117707489  Arnt; aryl hydrocarbon receptor nuclear translocator isoform X1 [KO:K09097]
117713883  Arnt2; aryl hydrocarbon receptor nuclear translocator 2 isoform X1 [KO:K15589]
117718741  Ep300; histone acetyltransferase p300 isoform X1 [KO:K04498] [EC:2.3.1.48]
117710697  Crebbp; CREB-binding protein isoform X1 [KO:K04498] [EC:2.3.1.48]
117708410  Slc2a1; solute carrier family 2, facilitated glucose transporter member 1 [KO:K07299]
117703754  Jag1; protein jagged-1 [KO:K06052]
117697531  Jag2; protein jagged-2 isoform X1 [KO:K21635]
117700281  Dll1; delta-like protein 1 [KO:K06051]
117719065  Dll3; delta-like protein 3 [KO:K06051]
117703466  Dll4; delta-like protein 4 [KO:K06051]
117710516  Notch1; neurogenic locus notch homolog protein 1 [KO:K02599]
117706733  Notch2; neurogenic locus notch homolog protein 2 [KO:K20994]
117696497  Notch3; neurogenic locus notch homolog protein 3 [KO:K20995]
117724864  Notch4; neurogenic locus notch homolog protein 4 [KO:K20996]
117718230  Hes1; transcription factor HES-1 [KO:K06054]
117708524  Hes5; transcription factor HES-5 [KO:K06055]
117708176  Heyl; hairy/enhancer-of-split related with YRPW motif-like protein [KO:K09091]
117701127  Hey2; hairy/enhancer-of-split related with YRPW motif protein 2 [KO:K09091]
117719385  Hey1; hairy/enhancer-of-split related with YRPW motif protein 1 [KO:K09091]
117710955  Flt4; vascular endothelial growth factor receptor 3 [KO:K05097] [EC:2.7.10.1]
117720757  Shh; sonic hedgehog protein [KO:K11988]
117713602  Ptch1; protein patched homolog 1 isoform X1 [KO:K06225]
117720733  Smo; smoothened homolog [KO:K06226]
117693485  Kif7; kinesin-like protein KIF7 isoform X1 [KO:K18806]
117715312  Sufu; suppressor of fused homolog isoform X1 [KO:K06229]
117696804  Gli1; zinc finger protein GLI1 [KO:K16797]
117716542  Gli2; zinc finger protein GLI2 [KO:K16798]
117714071  Gli3; transcriptional activator GLI3 [KO:K06230]
117704668  Bmp2; bone morphogenetic protein 2 [KO:K21283]
117706351  Bmp4; bone morphogenetic protein 4 [KO:K04662]
117722890  Hhip; hedgehog-interacting protein [KO:K06231]
117694561  Ar; androgen receptor [KO:K08557]
117722670  Hsp90ab1; heat shock protein HSP 90-beta [KO:K04079]
117697557  Hsp90aa1; heat shock protein HSP 90-alpha [KO:K04079]
117694347  LOW QUALITY PROTEIN: heat shock protein HSP 90-beta-like [KO:K04079]
117695077  LOW QUALITY PROTEIN: heat shock protein HSP 90-beta-like [KO:K04079]
117721709  heat shock protein HSP 90-beta-like [KO:K04079]
117696239  Hsp90b1; endoplasmin [KO:K09487]
Compound
C00027  Hydrogen peroxide
C00039  DNA
C00076  Calcium cation
C00122  Fumarate
C00149  (S)-Malate
C00165  Diacylglycerol
C00187  Cholesterol
C00280  Androstenedione
C00410  Progesterone
C00416  Phosphatidate
C00533  Nitric oxide
C00535  Testosterone
C00575  3',5'-Cyclic AMP
C00584  Prostaglandin E2
C00681  1-Acyl-sn-glycerol 3-phosphate
C00704  Superoxide
C00735  Cortisol
C00762  Cortisone
C00777  Retinoate
C00951  Estradiol-17beta
C01227  Dehydroepiandrosterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01471  Acrolein
C03917  Dihydrotestosterone
C05981  Phosphatidylinositol-3,4,5-trisphosphate
C07653  Flutamide
C15493  9-cis-Retinoic acid
C16038  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
C16844  Hydroxyl radical
C21641  Hydroperoxyl radical
C21642  4-Hydroxynonenal
Reference
  Authors
Weinberg RA.
  Title
The biology of cancer
  Journal
Garland Science, Taylor & Francis Group, LLC (2007)
Reference
  Authors
Hanahan D, Weinberg RA
  Title
The hallmarks of cancer.
  Journal
Cell 100:57-70 (2000)
DOI:10.1016/S0092-8674(00)81683-9
Reference
  Authors
Grady WM.
  Title
Genomic instability and colon cancer.
  Journal
Cancer Metastasis Rev 23:11-27 (2004)
DOI:10.1023/A:1025861527711
Reference
  Authors
Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.
  Title
Microsatellite instability in colorectal cancer.
  Journal
Br J Surg 93:395-406 (2006)
DOI:10.1002/bjs.5328
Reference
  Authors
Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.
  Title
Hereditary non-polyposis colorectal cancer: an updated review.
  Journal
Eur J Surg Oncol 26:635-45 (2000)
DOI:10.1053/ejso.2000.0974
Reference
  Authors
Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.
  Title
Colorectal cancer: genetics of development and metastasis.
  Journal
J Gastroenterol 41:185-92 (2006)
DOI:10.1007/s00535-006-1801-6
Reference
  Authors
Lynch HT, de la Chapelle A.
  Title
Hereditary colorectal cancer.
  Journal
N Engl J Med 348:919-32 (2003)
DOI:10.1056/NEJMra012242
Reference
  Authors
Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.
  Title
The significance of unstable chromosomes in colorectal cancer.
  Journal
Nat Rev Cancer 3:695-701 (2003)
DOI:10.1038/nrc1165
Reference
  Authors
Behrens J.
  Title
Cadherins and catenins: role in signal transduction and tumor progression.
  Journal
Cancer Metastasis Rev 18:15-30 (1999)
DOI:10.1023/A:1006200102166
Reference
  Authors
Behrens J.
  Title
The role of the Wnt signalling pathway in colorectal tumorigenesis.
  Journal
Biochem Soc Trans 33:672-5 (2005)
DOI:10.1042/BST0330672
Reference
  Authors
Behrens J, Lustig B.
  Title
The Wnt connection to tumorigenesis.
  Journal
Int J Dev Biol 48:477-87 (2004)
DOI:10.1387/ijdb.041815jb
Reference
PMID:9196022
  Authors
Polakis P.
  Title
The adenomatous polyposis coli (APC) tumor suppressor.
  Journal
Biochim Biophys Acta 1332:F127-47 (1997)
DOI:10.1016/S0304-419X(97)00008-5
Reference
  Authors
Janssen KP.
  Title
Murine models of colorectal cancer: studying the role of oncogenic K-ras.
  Journal
Cell Mol Life Sci 60:495-506 (2003)
DOI:10.1007/s000180300041
Reference
  Authors
Adjei AA.
  Title
Blocking oncogenic Ras signaling for cancer therapy.
  Journal
J Natl Cancer Inst 93:1062-74 (2001)
DOI:10.1093/jnci/93.14.1062
Reference
  Authors
Arakawa H.
  Title
Netrin-1 and its receptors in tumorigenesis.
  Journal
Nat Rev Cancer 4:978-87 (2004)
DOI:10.1038/nrc1504
Reference
  Authors
Mehlen P, Fearon ER.
  Title
Role of the dependence receptor DCC in colorectal cancer pathogenesis.
  Journal
J Clin Oncol 22:3420-8 (2004)
DOI:10.1200/JCO.2004.02.019
Reference
  Authors
Peltomaki P.
  Title
DNA mismatch repair and cancer.
  Journal
Mutat Res 488:77-85 (2001)
DOI:10.1016/S1383-5742(00)00058-2
Reference
  Authors
Li F, Cao Y, Townsend CM Jr, Ko TC.
  Title
TGF-beta signaling in colon cancer cells.
  Journal
World J Surg 29:306-11 (2005)
DOI:10.1007/s00268-004-7813-6
Reference
  Authors
Roman C, Saha D, Beauchamp R.
  Title
TGF-beta and colorectal carcinogenesis.
  Journal
Reference
  Authors
Watson AJ.
  Title
An overview of apoptosis and the prevention of colorectal cancer.
  Journal
Crit Rev Oncol Hematol 57:107-21 (2006)
DOI:10.1016/j.critrevonc.2005.06.005
Reference
  Authors
Watson AJ.
  Title
Apoptosis and colorectal cancer.
  Journal
Gut 53:1701-9 (2004)
DOI:10.1136/gut.2004.052704
Reference
  Authors
Houlston RS.
  Title
What we could do now: molecular pathology of colorectal cancer.
  Journal
Mol Pathol 54:206-14 (2001)
DOI:10.1136/mp.54.4.206
Reference
  Authors
Von Hoff D, Evans D, Hruban R (ed).
  Title
Pancreatic cancer
  Journal
Jones and Bartlett publishers (2005)
Reference
  Authors
Niitsu Y, Yokota J (ed).
  Title
[Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese)
  Journal
Nankodo (1999)
Reference
  Authors
Bardeesy N, DePinho RA.
  Title
Pancreatic cancer biology and genetics.
  Journal
Nat Rev Cancer 2:897-909 (2002)
DOI:10.1038/nrc949
Reference
  Authors
Bardeesy N, Sharpless NE, DePinho RA, Merlino G.
  Title
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.
  Journal
Semin Cancer Biol 11:201-18 (2001)
DOI:10.1006/scbi.2000.0371
Reference
  Authors
Cowgill SM, Muscarella P.
  Title
The genetics of pancreatic cancer.
  Journal
Am J Surg 186:279-86 (2003)
DOI:10.1016/S0002-9610(03)00226-5
Reference
  Authors
Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.
  Title
Genetics and biology of pancreatic ductal adenocarcinoma.
  Journal
Genes Dev 20:1218-49 (2006)
DOI:10.1101/gad.1415606
Reference
  Authors
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.
  Title
Understanding Ras: 'it ain't over 'til it's over'.
  Journal
Trends Cell Biol 10:147-54 (2000)
DOI:10.1016/S0962-8924(00)01740-2
Reference
  Authors
Holbro T, Civenni G, Hynes NE.
  Title
The ErbB receptors and their role in cancer progression.
  Journal
Exp Cell Res 284:99-110 (2003)
DOI:10.1016/S0014-4827(02)00099-X
Reference
  Authors
Marmor MD, Skaria KB, Yarden Y.
  Title
Signal transduction and oncogenesis by ErbB/HER receptors.
  Journal
Int J Radiat Oncol Biol Phys 58:903-13 (2004)
DOI:10.1016/j.ijrobp.2003.06.002
Reference
  Authors
DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.
  Title
Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.
  Journal
Oncogene 22:7781-95 (2003)
DOI:10.1038/sj.onc.1206966
Reference
  Authors
Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.
  Title
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.
  Journal
Oncogene 22:319-29 (2003)
DOI:10.1038/sj.onc.1206122
Reference
  Authors
Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.
  Title
Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.
  Journal
Cancer Lett 201:107-16 (2003)
DOI:10.1016/S0304-3835(03)00482-8
Reference
  Authors
Schmid RM.
  Title
Genetic basis of pancreatic cancer.
  Journal
Best Pract Res Clin Gastroenterol 16:421-33 (2002)
DOI:10.1053/bega.2002.0316
Reference
  Authors
Elliott RL, Blobe GC.
  Title
Role of transforming growth factor Beta in human cancer.
  Journal
J Clin Oncol 23:2078-93 (2005)
DOI:10.1200/JCO.2005.02.047
Reference
  Authors
Rudkin TM, Foulkes WD.
  Title
BRCA2: breaks, mistakes and failed separations.
  Journal
Trends Mol Med 11:145-8 (2005)
DOI:10.1016/j.molmed.2005.02.003
Reference
  Authors
Venkitaraman AR.
  Title
Functions of BRCA1 and BRCA2 in the biological response to DNA damage.
  Journal
J Cell Sci 114:3591-8 (2001)
Reference
  Authors
Soni D, King JA, Kaye AH, Hovens CM.
  Title
Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.
  Journal
J Clin Neurosci 12:1-5 (2005)
DOI:10.1016/j.jocn.2004.04.001
Reference
  Authors
Zhu Y, Parada LF.
  Title
The molecular and genetic basis of neurological tumours.
  Journal
Nat Rev Cancer 2:616-26 (2002)
DOI:10.1038/nrc866
Reference
  Authors
Holland EC.
  Title
Gliomagenesis: genetic alterations and mouse models.
  Journal
Nat Rev Genet 2:120-9 (2001)
DOI:10.1038/35052535
Reference
  Authors
Bansal K, Liang ML, Rutka JT.
  Title
Molecular biology of human gliomas.
  Journal
Technol Cancer Res Treat 5:185-94 (2006)
DOI:10.1177/153303460600500302
Reference
  Authors
Tabuchi K (ed).
  Title
[Gliomas: Research and therapy] (In Japanese)
  Journal
Springer-Verlag Tokyo (2006)
Reference
  Authors
Kapoor GS, O'Rourke DM.
  Title
Mitogenic signaling cascades in glial tumors.
  Journal
Neurosurgery 52:1425-34; discussion 1434-5 (2003)
DOI:10.1227/01.NEU.0000065135.28143.39
Reference
  Authors
Hulleman E, Helin K.
  Title
Molecular mechanisms in gliomagenesis.
  Journal
Adv Cancer Res 94:1-27 (2005)
DOI:10.1016/S0065-230X(05)94001-3
Reference
  Authors
Schlessinger J.
  Title
Cell signaling by receptor tyrosine kinases.
  Journal
Cell 103:211-25 (2000)
DOI:10.1016/S0092-8674(00)00114-8
Reference
PMID:9643506
  Authors
Ng HK, Lam PY.
  Title
The molecular genetics of central nervous system tumors.
  Journal
Pathology 30:196-202 (1998)
DOI:10.1080/00313029800169236
Reference
  Authors
Knobbe CB, Merlo A, Reifenberger G.
  Title
Pten signaling in gliomas.
  Journal
Neuro-oncol 4:196-211 (2002)
DOI:10.1093/neuonc/4.3.196
Reference
  Authors
Kondo T, Ezzat S, Asa SL.
  Title
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
  Journal
Nat Rev Cancer 6:292-306 (2006)
DOI:10.1038/nrc1836
Reference
  Authors
Chiloeches A, Marais R.
  Title
Is BRAF the Achilles' Heel of thyroid cancer?
  Journal
Clin Cancer Res 12:1661-4 (2006)
DOI:10.1158/1078-0432.CCR-06-0051
Reference
  Authors
Reddi HV, McIver B, Grebe SK, Eberhardt NL
  Title
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
  Journal
Endocrinology 148:932-5 (2007)
DOI:10.1210/en.2006-0926
Reference
  Authors
Santoro M, Melillo RM, Fusco A.
  Title
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
  Journal
Eur J Endocrinol 155:645-653 (2006)
DOI:10.1530/eje.1.02289
Reference
  Authors
Pierotti MA, Greco A.
  Title
Oncogenic rearrangements of the NTRK1/NGF receptor.
  Journal
Cancer Lett 232:90-8 (2006)
DOI:10.1016/j.canlet.2005.07.043
Reference
  Authors
Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.
  Title
Molecular pathology of well-differentiated thyroid carcinomas.
  Journal
Virchows Arch 447:787-93 (2005)
DOI:10.1007/s00428-005-0065-5
Reference
  Authors
Gimm O.
  Title
Thyroid cancer.
  Journal
Cancer Lett 163:143-56 (2001)
DOI:10.1016/S0304-3835(00)00697-2
Reference
  Authors
Williams D.
  Title
Cancer after nuclear fallout: lessons from the Chernobyl accident.
  Journal
Nat Rev Cancer 2:543-9 (2002)
DOI:10.1038/nrc845
Reference
  Authors
Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H.
  Title
The molecular pathogenesis of acute myeloid leukemia.
  Journal
Crit Rev Oncol Hematol 56:195-221 (2005)
DOI:10.1016/j.critrevonc.2004.10.012
Reference
  Authors
Tenen DG.
  Title
Disruption of differentiation in human cancer: AML shows the way.
  Journal
Nat Rev Cancer 3:89-101 (2003)
DOI:10.1038/nrc989
Reference
  Authors
Choudhary C, Muller-Tidow C, Berdel WE, Serve H.
  Title
Signal transduction of oncogenic Flt3.
  Journal
Int J Hematol 82:93-9 (2005)
DOI:10.1532/IJH97.05090
Reference
  Authors
Stirewalt DL, Radich JP.
  Title
The role of FLT3 in haematopoietic malignancies.
  Journal
Nat Rev Cancer 3:650-65 (2003)
DOI:10.1038/nrc1169
Reference
  Authors
Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C, Cocco L.
  Title
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.
  Journal
Leukemia 20:911-28 (2006)
DOI:10.1038/sj.leu.2404245
Reference
  Authors
Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R.
  Title
Normal and oncogenic forms of the receptor tyrosine kinase kit.
  Journal
Stem Cells 23:16-43 (2005)
DOI:10.1634/stemcells.2004-0117
Reference
  Authors
Lorsbach RB, Downing JR.
  Title
The role of the AML1 transcription factor in leukemogenesis.
  Journal
Int J Hematol 74:258-65 (2001)
DOI:10.1007/BF02982058
Reference
  Authors
Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Bohmer FD, Muller-Tidow C, Berdel WE, Serve H.
  Title
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.
  Journal
Blood 101:3164-73 (2003)
DOI:10.1182/blood-2002-06-1677
Reference
  Authors
Mikesch JH, Steffen B, Berdel WE, Serve H, Muller-Tidow C.
  Title
The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.
  Journal
Leukemia 21:1638-47 (2007)
DOI:10.1038/sj.leu.2404732
Reference
  Authors
Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG.
  Title
ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
  Journal
Blood 107:3330-8 (2006)
DOI:10.1182/blood-2005-07-3068
Reference
  Authors
Ren R.
  Title
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.
  Journal
Nat Rev Cancer 5:172-83 (2005)
DOI:10.1038/nrc1567
Reference
  Authors
Deininger MW, Goldman JM, Melo JV.
  Title
The molecular biology of chronic myeloid leukemia.
  Journal
Blood 96:3343-56 (2000)
Reference
  Authors
Calabretta B, Perrotti D.
  Title
The biology of CML blast crisis.
  Journal
Blood 103:4010-22 (2004)
DOI:10.1182/blood-2003-12-4111
Reference
  Authors
Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM.
  Title
The biology of chronic myeloid leukemia.
  Journal
N Engl J Med 341:164-72 (1999)
DOI:10.1056/NEJM199907153410306
Reference
  Authors
Mitani K.
  Title
Molecular mechanisms of leukemogenesis by AML1/EVI-1.
  Journal
Oncogene 23:4263-9 (2004)
DOI:10.1038/sj.onc.1207777
Reference
  Authors
Dong M, Blobe GC.
  Title
Role of transforming growth factor-beta in hematologic malignancies.
  Journal
Blood 107:4589-96 (2006)
DOI:10.1182/blood-2005-10-4169
Reference
PMID:9834202
  Authors
Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, Hirai H.
  Title
The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.
  Journal
Blood 92:4003-12 (1998)
Reference
  Authors
Brusa G, Benvenuti M, Mazzacurati L, Mancini M, Pattacini L, Martinelli G, Barbieri E, Greenberger JS, Baccarani M, Santucci MA.
  Title
p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.
  Journal
Haematologica 88:622-30 (2003)
Reference
  Authors
Baldwin AS.
  Title
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
  Journal
J Clin Invest 107:241-6 (2001)
DOI:10.1172/JCI11991
Reference
  Authors
Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL.
  Title
PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.
  Journal
Nat Med 8:1145-52 (2002)
DOI:10.1038/nm759
Reference
  Authors
Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC.
  Title
Molecular aetiology and pathogenesis of basal cell carcinoma.
  Journal
Br J Dermatol 152:1108-24 (2005)
DOI:10.1111/j.1365-2133.2005.06587.x
Reference
  Authors
Saldanha G, Fletcher A, Slater DN.
  Title
Basal cell carcinoma: a dermatopathological and molecular biological update.
  Journal
Br J Dermatol 148:195-202 (2003)
DOI:10.1046/j.1365-2133.2003.05151.x
Reference
  Authors
Daya-Grosjean L, Couve-Privat S.
  Title
Sonic hedgehog signaling in basal cell carcinomas.
  Journal
Cancer Lett 225:181-92 (2005)
DOI:10.1016/j.canlet.2004.10.003
Reference
  Authors
Tsai KY, Tsao H.
  Title
The genetics of skin cancer.
  Journal
Am J Med Genet C Semin Med Genet 131C:82-92 (2004)
DOI:10.1002/ajmg.c.30037
Reference
  Authors
Athar M, Tang X, Lee JL, Kopelovich L, Kim AL.
  Title
Hedgehog signalling in skin development and cancer.
  Journal
Exp Dermatol 15:667-77 (2006)
DOI:10.1111/j.1600-0625.2006.00473.x
Reference
  Authors
Rubin AI, Chen EH, Ratner D.
  Title
Basal-cell carcinoma.
  Journal
N Engl J Med 353:2262-9 (2005)
DOI:10.1056/NEJMra044151
Reference
  Authors
Saldanha G.
  Title
The Hedgehog signalling pathway and cancer.
  Journal
Reference
  Authors
Saldanha G, Ghura V, Potter L, Fletcher A.
  Title
Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.
  Journal
Br J Dermatol 151:157-64 (2004)
DOI:10.1111/j.1365-2133.2004.06048.x
Reference
  Authors
Pasca di Magliano M, Hebrok M.
  Title
Hedgehog signalling in cancer formation and maintenance.
  Journal
Nat Rev Cancer 3:903-11 (2003)
DOI:10.1038/nrc1229
Reference
  Authors
Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.
  Title
Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
  Journal
Br J Dermatol 152:43-51 (2005)
DOI:10.1111/j.1365-2133.2005.06353.x
Reference
  Authors
Cohen MM Jr.
  Title
The hedgehog signaling network.
  Journal
Am J Med Genet A 123:5-28 (2003)
DOI:10.1002/ajmg.a.20495
Reference
  Authors
Yamazaki F, Aragane Y, Kawada A, Tezuka T.
  Title
Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma.
  Journal
Br J Dermatol 145:771-7 (2001)
DOI:10.1046/j.1365-2133.2001.04468.x
Reference
  Authors
Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA.
  Title
Role of apoptosis in basal cell and squamous cell carcinoma formation.
  Journal
Immunol Lett 100:68-72 (2005)
DOI:10.1016/j.imlet.2005.06.008
Reference
  Authors
Toftgard R.
  Title
Hedgehog signalling in cancer.
  Journal
Cell Mol Life Sci 57:1720-31 (2000)
DOI:10.1007/PL00000654
Reference
  Authors
Miller AJ, Mihm MC Jr.
  Title
Melanoma.
  Journal
N Engl J Med 355:51-65 (2006)
DOI:10.1056/NEJMra052166
Reference
  Authors
Chin L.
  Title
The genetics of malignant melanoma: lessons from mouse and man.
  Journal
Nat Rev Cancer 3:559-70 (2003)
DOI:10.1038/nrc1145
Reference
  Authors
Takata M, Saida T.
  Title
Genetic alterations in melanocytic tumors.
  Journal
J Dermatol Sci 43:1-10 (2006)
DOI:10.1016/j.jdermsci.2006.05.002
Reference
  Authors
Chudnovsky Y, Khavari PA, Adams AE.
  Title
Melanoma genetics and the development of rational therapeutics.
  Journal
J Clin Invest 115:813-24 (2005)
DOI:10.1172/JCI24808
Reference
  Authors
Merlino G.
  Title
Cancer biology: the weakest link?
  Journal
Nature 436:33-5 (2005)
DOI:10.1038/436033a
Reference
  Authors
Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.
  Title
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
  Journal
Nature 436:117-22 (2005)
DOI:10.1038/nature03664
Reference
  Authors
Levy C, Khaled M, Fisher DE.
  Title
MITF: master regulator of melanocyte development and melanoma oncogene.
  Journal
Trends Mol Med 12:406-14 (2006)
DOI:10.1016/j.molmed.2006.07.008
Reference
  Authors
Tsao H, Goel V, Wu H, Yang G, Haluska FG.
  Title
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
  Journal
J Invest Dermatol 122:337-41 (2004)
DOI:10.1046/j.0022-202X.2004.22243.x
Reference
  Authors
Gruss C, Herlyn M.
  Title
Role of cadherins and matrixins in melanoma.
  Journal
Curr Opin Oncol 13:117-23 (2001)
DOI:10.1097/00001622-200103000-00006
Reference
  Authors
Thompson JF, Scolyer RA, Kefford RF.
  Title
Cutaneous melanoma.
  Journal
Lancet 365:687-701 (2005)
DOI:10.1016/S0140-6736(05)17951-3
Reference
  Authors
Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.
  Title
NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.
  Journal
Clin Cancer Res 9:6483-8 (2003)
Reference
  Authors
Hussein MR.
  Title
The TP53 tumor suppressor gene and melanoma tumorigenesis: is there a relationship?
  Journal
Tumour Biol 25:200-7 (2004)
DOI:10.1159/000081103
Reference
  Authors
Lazar-Molnar E, Hegyesi H, Toth S, Falus A.
  Title
Autocrine and paracrine regulation by cytokines and growth factors in melanoma.
  Journal
Cytokine 12:547-54 (2000)
DOI:10.1006/cyto.1999.0614
Reference
  Authors
Cohen HT, McGovern FJ.
  Title
Renal-cell carcinoma.
  Journal
N Engl J Med 353:2477-90 (2005)
DOI:10.1056/NEJMra043172
Reference
  Authors
Pavlovich CP, Schmidt LS.
  Title
Searching for the hereditary causes of renal-cell carcinoma.
  Journal
Nat Rev Cancer 4:381-93 (2004)
DOI:10.1038/nrc1364
Reference
  Authors
Linehan WM, Walther MM, Zbar B.
  Title
The genetic basis of cancer of the kidney.
  Journal
J Urol 170:2163-72 (2003)
DOI:10.1097/01.ju.0000096060.92397.ed
Reference
  Authors
Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.
  Title
Met, metastasis, motility and more.
  Journal
Nat Rev Mol Cell Biol 4:915-25 (2003)
DOI:10.1038/nrm1261
Reference
  Authors
Kim WY, Kaelin WG.
  Title
Role of VHL gene mutation in human cancer.
  Journal
J Clin Oncol 22:4991-5004 (2004)
DOI:10.1200/JCO.2004.05.061
Reference
  Authors
Sudarshan S, Linehan WM, Neckers L.
  Title
HIF and fumarate hydratase in renal cancer.
  Journal
Br J Cancer 96:403-7 (2007)
DOI:10.1038/sj.bjc.6603547
Reference
  Authors
Sudarshan S, Pinto PA, Neckers L, Linehan WM.
  Title
Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.
  Journal
Nat Clin Pract Urol 4:104-10 (2007)
DOI:10.1038/ncpuro0711
Reference
  Authors
Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.
  Title
Understanding familial and non-familial renal cell cancer.
  Journal
Hum Mol Genet 11:2489-98 (2002)
DOI:10.1093/hmg/11.20.2489
Reference
  Authors
Mitra AP, Datar RH, Cote RJ.
  Title
Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.
  Journal
J Clin Oncol 24:5552-64 (2006)
DOI:10.1200/JCO.2006.08.2073
Reference
  Authors
Wolff EM, Liang G, Jones PA.
  Title
Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.
  Journal
Nat Clin Pract Urol 2:502-10 (2005)
DOI:10.1038/ncpuro0318
Reference
  Authors
Wu XR.
  Title
Urothelial tumorigenesis: a tale of divergent pathways.
  Journal
Nat Rev Cancer 5:713-25 (2005)
DOI:10.1038/nrc1697
Reference
  Authors
Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R.
  Title
Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.
  Journal
Cancer Res 60:6298-302 (2000)
Reference
  Authors
Bellmunt J, Hussain M, Dinney CP.
  Title
Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.
  Journal
Crit Rev Oncol Hematol 46 Suppl:S85-104 (2003)
DOI:10.1016/S1040-8428(03)00067-2
Reference
  Authors
Sugano K, Kakizoe T.
  Title
Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.
  Journal
Nat Clin Pract Urol 3:642-52 (2006)
DOI:10.1038/ncpuro0649
Reference
  Authors
Dunn KL, Espino PS, Drobic B, He S, Davie JR.
  Title
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
  Journal
Biochem Cell Biol 83:1-14 (2005)
DOI:10.1139/o04-121
Reference
  Authors
Williams SG, Stein JP.
  Title
Molecular pathways in bladder cancer.
  Journal
Urol Res 32:373-85 (2004)
DOI:10.1007/s00240-003-0345-y
Reference
  Authors
Nelson WG, De Marzo AM, Isaacs WB.
  Title
Prostate cancer.
  Journal
N Engl J Med 349:366-81 (2003)
DOI:10.1056/NEJMra021562
Reference
  Authors
Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC.
  Title
The emerging role of the PI3-K-Akt pathway in prostate cancer progression.
  Journal
Prostate Cancer Prostatic Dis 8:108-18 (2005)
DOI:10.1038/sj.pcan.4500776
Reference
  Authors
Pienta KJ, Bradley D.
  Title
Mechanisms underlying the development of androgen-independent prostate cancer.
  Journal
Clin Cancer Res 12:1665-71 (2006)
DOI:10.1158/1078-0432.CCR-06-0067
Reference
  Authors
Feldman BJ, Feldman D.
  Title
The development of androgen-independent prostate cancer.
  Journal
Nat Rev Cancer 1:34-45 (2001)
DOI:10.1038/35094009
Reference
  Authors
Heinlein CA, Chang C.
  Title
Androgen receptor in prostate cancer.
  Journal
Endocr Rev 25:276-308 (2004)
DOI:10.1210/er.2002-0032
Reference
PMID:9422516
  Authors
Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP.
  Title
Androgen receptor gene and hormonal therapy failure of prostate cancer.
  Journal
Am J Pathol 152:1-9 (1998)
Reference
  Authors
Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D.
  Title
Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.
  Journal
Nat Med 6:703-6 (2000)
DOI:10.1038/76287
Reference
  Authors
Macri E, Loda M.
  Title
Role of p27 in prostate carcinogenesis.
  Journal
Cancer Metastasis Rev 17:337-44 (1998)
DOI:10.1023/A:1006133620914
Reference
  Authors
Steers WD.
  Title
5alpha-reductase activity in the prostate.
  Journal
Urology 58:17-24; discussion 24 (2001)
DOI:10.1016/S0090-4295(01)01299-7
Reference
PMID:8069858
  Authors
Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF.
  Title
Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.
  Journal
Cancer Res 54:4920-6 (1994)
Reference
  Authors
Grimes CA, Jope RS.
  Title
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.
  Journal
Prog Neurobiol 65:391-426 (2001)
DOI:10.1016/S0301-0082(01)00011-9
Reference
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Reference
  Authors
Sanchez-Cespedes M.
  Title
Dissecting the genetic alterations involved in lung carcinogenesis.
  Journal
Lung Cancer 40:111-21 (2003)
DOI:10.1016/S0169-5002(03)00033-3
Reference
  Authors
Kaye FJ.
  Title
Molecular biology of lung cancer.
  Journal
Lung Cancer 34 Suppl 2:S35-41 (2001)
DOI:10.1016/S0169-5002(01)00342-7
Reference
  Authors
Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF.
  Title
Apoptosis and lung cancer: a review.
  Journal
J Cell Biochem 88:885-98 (2003)
DOI:10.1002/jcb.10440
Reference
  Authors
Sartorius UA, Krammer PH.
  Title
Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines.
  Journal
Int J Cancer 97:584-92 (2002)
DOI:10.1002/ijc.10096
Reference
  Authors
Adhikary S, Eilers M.
  Title
Transcriptional regulation and transformation by Myc proteins.
  Journal
Nat Rev Mol Cell Biol 6:635-45 (2005)
DOI:10.1038/nrm1703
Reference
  Authors
Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI.
  Title
A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.
  Journal
Mol Cell 7:639-50 (2001)
DOI:10.1016/S1097-2765(01)00210-6
Reference
  Authors
Buttery RC, Rintoul RC, Sethi T.
  Title
Small cell lung cancer: the importance of the extracellular matrix.
  Journal
Int J Biochem Cell Biol 36:1154-60 (2004)
DOI:10.1016/S1357-2725(03)00261-9
Reference
  Authors
Yamada KM, Araki M.
  Title
Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.
  Journal
J Cell Sci 114:2375-82 (2001)
Reference
  Authors
Rintoul RC, Sethi T.
  Title
The role of extracellular matrix in small-cell lung cancer.
  Journal
Lancet Oncol 2:437-42 (2001)
DOI:10.1016/S1470-2045(00)00421-6
Reference
  Authors
Ekedahl J, Joseph B, Grigoriev MY, Muller M, Magnusson C, Lewensohn R, Zhivotovsky B.
  Title
Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.
  Journal
Exp Cell Res 279:277-90 (2002)
DOI:10.1006/excr.2002.5608
Reference
  Authors
Osada H, Takahashi T.
  Title
Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
  Journal
Oncogene 21:7421-34 (2002)
DOI:10.1038/sj.onc.1205802
Reference
  Authors
Yokota J, Nishioka M, Tani M, Kohno T.
  Title
Genetic alterations responsible for metastatic phenotypes of lung cancer cells.
  Journal
Clin Exp Metastasis 20:189-93 (2003)
DOI:10.1023/a:1022978932215
Reference
  Authors
Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS.
  Title
K-ras mutations in non-small-cell lung carcinoma: a review.
  Journal
Clin Lung Cancer 8:30-8 (2006)
DOI:10.3816/CLC.2006.n.030
Reference
  Authors
Pfeifer GP, Dammann R.
  Title
Methylation of the tumor suppressor gene RASSF1A in human tumors.
  Journal
Biochemistry (Mosc) 70:576-83 (2005)
DOI:10.1007/s10541-005-0151-y
Reference
  Authors
Altucci L, Gronemeyer H.
  Title
The promise of retinoids to fight against cancer.
  Journal
Nat Rev Cancer 1:181-93 (2001)
DOI:10.1038/35106036
Reference
  Authors
Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.
  Title
Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.
  Journal
J Natl Cancer Inst 92:1303-7 (2000)
DOI:10.1093/jnci/92.16.1303
Reference
  Authors
Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA.
  Title
Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.
  Journal
Lung Cancer 41 Suppl 1:S29-42 (2003)
DOI:10.1016/S0169-5002(03)00137-5
Reference
  Authors
Panani AD, Roussos C.
  Title
Cytogenetic and molecular aspects of lung cancer.
  Journal
Cancer Lett 239:1-9 (2006)
DOI:10.1016/j.canlet.2005.06.030
Reference
  Authors
Mitsuuchi Y, Testa JR.
  Title
Cytogenetics and molecular genetics of lung cancer.
  Journal
Am J Med Genet 115:183-8 (2002)
DOI:10.1002/ajmg.10692
Reference
  Authors
Breuer RH, Postmus PE, Smit EF.
  Title
Molecular pathology of non-small-cell lung cancer.
  Journal
Respiration 72:313-30 (2005)
DOI:10.1159/000085376
Reference
  Authors
Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC, Grizzle WE.
  Title
Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
  Journal
Clin Cancer Res 8:734-44 (2002)
Reference
  Authors
Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.
  Title
Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
  Journal
J Clin Pathol 58:1076-80 (2005)
DOI:10.1136/jcp.2004.025585
Reference
  Authors
Lappano R, Maggiolini M
  Title
G protein-coupled receptors: novel targets for drug discovery in cancer.
  Journal
Nat Rev Drug Discov 10:47-60 (2011)
DOI:10.1038/nrd3320
Reference
  Authors
O'Hayre M, Degese MS, Gutkind JS
  Title
Novel insights into G protein and G protein-coupled receptor signaling in cancer.
  Journal
Curr Opin Cell Biol 27:126-35 (2014)
DOI:10.1016/j.ceb.2014.01.005
Reference
  Authors
Dorsam RT, Gutkind JS
  Title
G-protein-coupled receptors and cancer.
  Journal
Nat Rev Cancer 7:79-94 (2007)
DOI:10.1038/nrc2069
Related
pathway
anu03320  PPAR signaling pathway
anu04010  MAPK signaling pathway
anu04020  Calcium signaling pathway
anu04024  cAMP signaling pathway
anu04060  Cytokine-cytokine receptor interaction
anu04066  HIF-1 signaling pathway
anu04110  Cell cycle
anu04115  p53 signaling pathway
anu04150  mTOR signaling pathway
anu04151  PI3K-Akt signaling pathway
anu04210  Apoptosis
anu04310  Wnt signaling pathway
anu04330  Notch signaling pathway
anu04340  Hedgehog signaling pathway
anu04350  TGF-beta signaling pathway
anu04370  VEGF signaling pathway
anu04510  Focal adhesion
anu04512  ECM-receptor interaction
anu04520  Adherens junction
anu04630  JAK-STAT signaling pathway
anu04915  Estrogen signaling pathway
KO pathway
ko05200   
LinkDB

DBGET integrated database retrieval system